Shanghai ABA Chemicals Co., Ltd.

ABA Chemicals Corporation was founded in 2003 and listed on the Shenzhen Stock Exchange in 2011. It is a professional technology-based enterprise in the life and health sector, integrating high-end customized R&D and production with high-quality green and healthy product services. Based in Shanghai and backed by the Yangtze River Delta, the most dynamic, open, and innovative region in China, ABA Chemicals has been committed to the R&D and production of plant protection products, pharmaceutical intermediates, and nutritional supplements for nearly two decades, holding a leading position in the fine chemical industry. From 2018 to 2021, the company was awarded the title of "China's Top 100 Fine Chemical Enterprises" for four consecutive years, establishing the brand advantage of "ABA Smart Manufacturing." Currently, it has completed the layout of seven production bases, including Malta in Europe, Taicang in Suzhou, Rudong in Nantong, Binhai in Yancheng, Xiangyang in Hubei, Shangrao in Jiangxi, and Shangyu in Zhejiang. ABA Chemicals boasts an excellent R&D team, led by provincial-level talents, with nearly 40% of members holding doctoral or master's degrees. It has established three major R&D centers, with the Shanghai Zhangjiang Innovation Center, Puyi Chemistry, and Yihui Biology as the core, covering a total R&D area of over 10,000 square meters. The company has led numerous national, provincial, and municipal government research and industrialization demonstration projects, receiving various honors from government departments and strategic partners. As a pioneer in the life and health field, ABA Chemicals continuously enhances its core technology and technical barriers in the business of innovative intermediate products, focusing on the R&D of innovative plant protection and pharmaceutical products, driving process innovation of pipeline products. Leveraging its outstanding independent R&D capabilities and excellent intelligent manufacturing system, it has built world-class production lines and supporting environmental facilities in accordance with Industry 4.0 standards, with all production lines achieving DCS automatic control, creating significant economic and social benefits. Over the years, ABA Chemicals has maintained cooperation with multinational companies including Corteva, Bayer, FMC, Roche Pharmaceuticals, AbbVie, Novartis, Teva Pharmaceuticals, Daiichi Sankyo, and Sumitomo Chemical, establishing stable strategic partnerships and accumulating substantial capital and strong technical strength. In the health product business, ABA Chemicals fully utilizes its technological and supply chain advantages, leveraging its synthetic biology platform and leading new enzyme technologies and processes to empower the health business, deeply exploring product market segments, developing a series of high-quality products targeting specific groups such as the elderly, women, and children, achieving product diversification and providing consumers with one-stop health improvement solutions. ABA Chemicals has introduced and absorbed DuPont's sustainable development DSS system, fundamentally improving and enhancing its safety production management level. Additionally, ABA Chemicals has sponsored for many years the Fudan University "Jinsi Forum" contemporary chemists' high-end forum, the Fudan University * Watershed Pollution Control Research Laboratory, and the China Homogeneous Catalysis Youth Award projects, and has invested in multiple environmental protection enterprises such as Anyang Aierwang, contributing to the national "dual carbon economy" initiative.